Aikelaimu A, Li W, Kaicaier M, Liu S, et al. Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy in breast cancer: a systematic review and meta-analysis with focus on triple-negative subtype and immune-related adverse events. BMC Cancer 2026 Jan 19. doi: 10.1186/s12885-025-15521.
PMID: 41555292